Drug–drug interaction through molecular structure similarity analysis

BACKGROUND: Drug–drug interactions (DDIs) are responsible for many serious adverse events; their detection is crucial for patient safety but is very challenging. Currently, the US Food and Drug Administration and pharmaceutical companies are showing great interest in the development of improved tool...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vilar, Santiago, Harpaz, Rave, Uriarte, Eugenio, Santana, Lourdes, Rabadan, Raul, Friedman, Carol
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2012
Assuntos:
Research and Applications
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3534468/
https://ncbi.nlm.nih.gov/pubmed/22647690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/amiajnl-2012-000935
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados